Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sabina Åke, Lena Hartelius, Asgeir S. Jakola & Malin Antonsson. (2023) Experiences of language and communication after brain-tumour treatment: A long-term follow-up after glioma surgery. Neuropsychological Rehabilitation 33:7, pages 1225-1261.
Read now
Read now
Sarah El-Wahsh, Claire Layfield, Hans Bogaardt, Fiona Kumfor & Kirrie J. Ballard. (2022) Perspectives from the patient: A content analysis of communication changes, impact, and strategies to facilitate communication in multiple sclerosis. International Journal of Speech-Language Pathology 24:2, pages 173-189.
Read now
Read now
Margaret Walshe & Nick Miller. (2011) Living with acquired dysarthria: the speaker's perspective. Disability and Rehabilitation 33:3, pages 195-203.
Read now
Read now
Lara Stepleman, Marie-Christine Rutter, Judith Hibbard, Lisa Johns, Dustin Wright & Mary Hughes. (2010) Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care. Disability and Rehabilitation 32:19, pages 1558-1567.
Read now
Read now
Articles from other publishers (16)
Sarah El‐Wahsh, Susan Balandin, Hans Bogaardt, Fiona Kumfor & Kirrie J. Ballard. (2022) Managing communication changes in persons with multiple sclerosis: Findings from qualitative focus groups. International Journal of Language & Communication Disorders 57:3, pages 680-694.
Crossref
Crossref
Julie A. Campbell, Sally N. Shaw, Casey Mainsbridge, Bruce V. Taylor & Suzi B. Claflin. (2022) An exploratory study regarding communication facilitators and barriers reported by a cohort of multiple sclerosis (MS) community members from the international massive open online course ‘Understanding MS’. Multiple Sclerosis and Related Disorders 59, pages 103473.
Crossref
Crossref
Seada A Kassie, Jannat Alia & Lynda Hyland. (2021) Biopsychosocial implications of living with multiple sclerosis: a qualitative study using interpretative phenomenological analysis. BMJ Open 11:8, pages e049041.
Crossref
Crossref
Allyson D. Page, Nada Elhayek, Carolyn Baylor, Scott Adams, Mandar Jog & Kathryn Yorkston. (2021) Exploring the Psychosocial Impact of Botulinum Toxin Type A Injections for Individuals With Oromandibular Dystonia: A Qualitative Study of Patients' Experiences. American Journal of Speech-Language Pathology 30:3S, pages 1314-1328.
Crossref
Crossref
Míde Power, Nora Arafa, Anke Wenz & Geraldine Foley. (2021) Perceptions of fatigue and fatigue management interventions among people with multiple sclerosis: a systematic literature review and narrative synthesis. International Journal of Therapy and Rehabilitation 28:6, pages 1-21.
Crossref
Crossref
Kathryn C Fitzgerald, Bridget Morris, Aurash Soroosh, Alexandra Balshi, Dermot Maher, Adam Kaplin & Bardia Nourbakhsh. (2020) Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis–related fatigue. Multiple Sclerosis Journal 27:6, pages 942-953.
Crossref
Crossref
Catherine F. Siengsukon, Mohammed Alshehri, Cierra Williams, Michelle Drerup & Sharon Lynch. (2020) Feasibility and treatment effect of cognitive behavioral therapy for insomnia in individuals with multiple sclerosis: A pilot randomized controlled trial. Multiple Sclerosis and Related Disorders 40, pages 101958.
Crossref
Crossref
Sarah El-Wahsh, Kirrie Ballard, Fiona Kumfor & Hans Bogaardt. (2020) Prevalence of self-reported language impairment in multiple sclerosis and the association with health-related quality of life: An international survey study. Multiple Sclerosis and Related Disorders 39, pages 101896.
Crossref
Crossref
Allyson D. Page, Lauren H. Siegel, Carolyn R. Baylor, Scott G. Adams & Kathryn M. Yorkston. (2019) The Consequences of Oromandibular Dystonia on Communicative Participation: A Qualitative Study of the Insider's Experiences. American Journal of Speech-Language Pathology 28:2S, pages 771-783.
Crossref
Crossref
Bardia Nourbakhsh, Nisha Revirajan & Emmanuelle Waubant. (2018) Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial. Contemporary Clinical Trials 64, pages 67-76.
Crossref
Crossref
Diana Bruno, Fatima Pagani Cassará, Vladimiro Sinay, Teresa Torralva, Facundo Manes & María Roca. (2017) Impacto de la fatiga y los síntomas anímicos en el funcionamiento cognitivo en pacientes con esclerosis múltiple en brote remisión. Neurología Argentina 9:1, pages 19-26.
Crossref
Crossref
J. J. Fernández-Muñoz, A. Morón-Verdasco, M. Cigarán-Méndez, E. Muñoz-Hellín, M. Pérez-de-Heredia-Torres & C. Fernández-de-las-Peñas. (2015) Disability, quality of life, personality, cognitive and psychological variables associated with fatigue in patients with multiple sclerosis. Acta Neurologica Scandinavica 132:2, pages 118-124.
Crossref
Crossref
Chrisma Pretorius & Ninon Joubert. (2014) The experiences of individuals with Multiple Sclerosis in the Western Cape, South Africa. Health SA Gesondheid 19:1.
Crossref
Crossref
Ahmed Toosy, Olga Ciccarelli & Alan Thompson. 2014. Multiple Sclerosis and Related Disorders. Multiple Sclerosis and Related Disorders
513
562
.
Carolyn Baylor, Michael Burns, Tanya Eadie, Deanna Britton & Kathryn Yorkston. (2011) A Qualitative Study of Interference With Communicative Participation Across Communication Disorders in Adults. American Journal of Speech-Language Pathology 20:4, pages 269-287.
Crossref
Crossref
John F. FoleyDavid W. Brandes. (2009) Redefining functionality and treatment efficacy in multiple sclerosis. Neurology 72:23_supplement_5.
Crossref
Crossref